Iterum Therapeutics Plc (ITRM)

$0.03 -0.04 (-57.39%)
Market Cap 1.60M
Revenue (ttm) 0.00
Net Income (ttm) -24.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -2.88
Volume 65,735,500
Avg Vol 19,797,338
Day's Range N/A - N/A
Shares Out 53.29M
Stochastic %K 2%
Beta 2.96
Analysts Hold
Price Target $9.00

Company Profile

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel...

Industry: Biotechnology
Sector: Healthcare
Phone: 353 1 903 8354
Address:
3 Dublin Landings, North Wall Quay, Dublin, Ireland
dnangel
dnangel May. 14 at 12:41 AM
$ITRM whats next dates ?
0 · Reply
Biorocksme
Biorocksme May. 13 at 11:43 PM
$ITRM Note Shionogi down over7% since their earnings. They have a full agenda to prove their new additions will show revenue and profits. Doubt they want more. Bluejepa is doing its targeted launch now. Plus Gsk already in trials in Asia/ Japan and with successful results. Orlynvah overseas will require huge funding for trials to see potential efficacy for genetics/Asia studies. Big question. GSK knows how to address market entry pushz.
0 · Reply
Amb8675309
Amb8675309 May. 13 at 10:07 PM
$ITRM #ladderofaccountability  Or you can blame Wall Street/big Pharma and tell me that no one cares about women’s health but then you can explain SPRO you can explain BARDA/ anti infective initiatives . You can’t explain all these other companies like SPRO, Shionogi etc. He’s the victim. Or maybe he was just a really poor steward of a great molecule. Whatever happens it’s a great learning experience. I hope we all learn something and when you spot a rat or basically somebody punching away above their weight who really isn’t the right person to handle the marketing of a drug like this that we just say not you’re not gonna drive our share value our hard earned money down to five cents. You can do it on someone else’s dime.
0 · Reply
Amb8675309
Amb8675309 May. 13 at 10:00 PM
$ITRM what did we learn from all of this?: 1) beware micro cap biotech with limited cash runway, even if drug is promising. Launches cost $ 2) beware CEO/CFO with low share counts/ won’t add more shares 3) beware CEO who’s a poor/infrequent communicator 4) beware CEO who does a PIPE below fair market value and goes to extreme lengths to hide identity of PIPE buyer 5) Launch should be cued up to hit ground running the DAY of FDA approval- not 10 months later 6) beware CEO who won’t tell you how launch is going 7) beware CEO who wants retail to vote yes/dilute shares but won’t buy more shares or open launch kimono. 8) beware CEO who’s only been a CFO, nominated himself CEO & isn’t a strong sales/visionary type. If he’s not painting us a clear, compelling vision & showing us how to get there➡️red flag 9) beware CEO/CFO who can’t find any cash and only hit us up for cash. Come on, you coulda’t find even crypto bros to fund this? 10) even if science is amazing, if you smell a rat..
1 · Reply
Amb8675309
Amb8675309 May. 13 at 9:40 PM
$ITRM he did back to back proxies but never came to us to tell us how the launch was going even in the last week or so he just hit us with back-to-back proxies in one minute. He’s asking for 80,000,000+ he wants 4 million for key hires, which is code for himself and Judi next minute he drops it to 50 and then he removes the 4 million shares for staff. He was all over the place but he never communicated with us other than the eight case he was going through the motions people there’s another deal we don’t know about. I never saw this guy be upset enough the way you or I would be upset if you’re about to lose $5 million or more again this guy is not worth 100 million bucks. I researched the house he bought- it is not the house of a dude worth even $50 million. This guy put a lot of his own personal money into this which is what he told me and he was going through the motions at the end. I did not see real pain that you and I would have losing 5 million bucks. There’s a side deal.
1 · Reply
Amb8675309
Amb8675309 May. 13 at 9:34 PM
$ITRM there was a point where I could clearly discern his heart was not in this. I could see it early on. He just didn’t seem to have a fight in him. You could say that he gave up but again this guy sunk five to $10 million into this so there was some other way he was gonna be whole. Otherwise he would’ve been way more desperate. He would’ve given us some sort of update. He would’ve appeal to us before the proxies. I think he was going through the motions because there’s a secret side arrangement that we don’t know about and given where we’re at right now with a current administration and there’s all kinds of insider trading he probably felt like no one‘s gonna know, but I don’t trust this guy as far as I can throw him and there’s some sort of side deal and then at the very end why is Judy Matthews being rehired in less than a month when she was supposed to be in charge of money procurement.
0 · Reply
DollerADay
DollerADay May. 13 at 9:12 PM
$ITRM The last reported period was Q3 2025. None of the language in the liquidation 8K and associated PR is normal. They even used “modest” sales when they can only refer to the only published Q3 commercialization period that contained 6-8 weeks of skeleton crew sales. They announced liquidation on 3/27, two business days before all Q1 reporting obligations would be required. We’ve been in the dark for 8 months, including Q1 when all three PBM and Medicare D coverage kicked. We also have extremely abnormal volume, price and support at this stage for a company in liquidation. Then of course there is the asset itself, of which, there has never been one close to this power and de-risking attributes in liquidation or bk. The HC and Cregan is likely asking a lot of questions and requesting statements from the board on how/why they ended up here with an asset that had and have buyers lined up.
0 · Reply
1stPlace
1stPlace May. 13 at 7:16 PM
$ITRM Does anyone know if the bidders know who each are? Can they see who is bidding and what the amounts are or it is unknown?
3 · Reply
thasif1991
thasif1991 May. 13 at 6:49 PM
$ITRM waiting for new predictions!!!
0 · Reply
Digger22
Digger22 May. 13 at 6:14 PM
$ITRM
0 · Reply
Latest News on ITRM
No data available.
dnangel
dnangel May. 14 at 12:41 AM
$ITRM whats next dates ?
0 · Reply
Biorocksme
Biorocksme May. 13 at 11:43 PM
$ITRM Note Shionogi down over7% since their earnings. They have a full agenda to prove their new additions will show revenue and profits. Doubt they want more. Bluejepa is doing its targeted launch now. Plus Gsk already in trials in Asia/ Japan and with successful results. Orlynvah overseas will require huge funding for trials to see potential efficacy for genetics/Asia studies. Big question. GSK knows how to address market entry pushz.
0 · Reply
Amb8675309
Amb8675309 May. 13 at 10:07 PM
$ITRM #ladderofaccountability  Or you can blame Wall Street/big Pharma and tell me that no one cares about women’s health but then you can explain SPRO you can explain BARDA/ anti infective initiatives . You can’t explain all these other companies like SPRO, Shionogi etc. He’s the victim. Or maybe he was just a really poor steward of a great molecule. Whatever happens it’s a great learning experience. I hope we all learn something and when you spot a rat or basically somebody punching away above their weight who really isn’t the right person to handle the marketing of a drug like this that we just say not you’re not gonna drive our share value our hard earned money down to five cents. You can do it on someone else’s dime.
0 · Reply
Amb8675309
Amb8675309 May. 13 at 10:00 PM
$ITRM what did we learn from all of this?: 1) beware micro cap biotech with limited cash runway, even if drug is promising. Launches cost $ 2) beware CEO/CFO with low share counts/ won’t add more shares 3) beware CEO who’s a poor/infrequent communicator 4) beware CEO who does a PIPE below fair market value and goes to extreme lengths to hide identity of PIPE buyer 5) Launch should be cued up to hit ground running the DAY of FDA approval- not 10 months later 6) beware CEO who won’t tell you how launch is going 7) beware CEO who wants retail to vote yes/dilute shares but won’t buy more shares or open launch kimono. 8) beware CEO who’s only been a CFO, nominated himself CEO & isn’t a strong sales/visionary type. If he’s not painting us a clear, compelling vision & showing us how to get there➡️red flag 9) beware CEO/CFO who can’t find any cash and only hit us up for cash. Come on, you coulda’t find even crypto bros to fund this? 10) even if science is amazing, if you smell a rat..
1 · Reply
Amb8675309
Amb8675309 May. 13 at 9:40 PM
$ITRM he did back to back proxies but never came to us to tell us how the launch was going even in the last week or so he just hit us with back-to-back proxies in one minute. He’s asking for 80,000,000+ he wants 4 million for key hires, which is code for himself and Judi next minute he drops it to 50 and then he removes the 4 million shares for staff. He was all over the place but he never communicated with us other than the eight case he was going through the motions people there’s another deal we don’t know about. I never saw this guy be upset enough the way you or I would be upset if you’re about to lose $5 million or more again this guy is not worth 100 million bucks. I researched the house he bought- it is not the house of a dude worth even $50 million. This guy put a lot of his own personal money into this which is what he told me and he was going through the motions at the end. I did not see real pain that you and I would have losing 5 million bucks. There’s a side deal.
1 · Reply
Amb8675309
Amb8675309 May. 13 at 9:34 PM
$ITRM there was a point where I could clearly discern his heart was not in this. I could see it early on. He just didn’t seem to have a fight in him. You could say that he gave up but again this guy sunk five to $10 million into this so there was some other way he was gonna be whole. Otherwise he would’ve been way more desperate. He would’ve given us some sort of update. He would’ve appeal to us before the proxies. I think he was going through the motions because there’s a secret side arrangement that we don’t know about and given where we’re at right now with a current administration and there’s all kinds of insider trading he probably felt like no one‘s gonna know, but I don’t trust this guy as far as I can throw him and there’s some sort of side deal and then at the very end why is Judy Matthews being rehired in less than a month when she was supposed to be in charge of money procurement.
0 · Reply
DollerADay
DollerADay May. 13 at 9:12 PM
$ITRM The last reported period was Q3 2025. None of the language in the liquidation 8K and associated PR is normal. They even used “modest” sales when they can only refer to the only published Q3 commercialization period that contained 6-8 weeks of skeleton crew sales. They announced liquidation on 3/27, two business days before all Q1 reporting obligations would be required. We’ve been in the dark for 8 months, including Q1 when all three PBM and Medicare D coverage kicked. We also have extremely abnormal volume, price and support at this stage for a company in liquidation. Then of course there is the asset itself, of which, there has never been one close to this power and de-risking attributes in liquidation or bk. The HC and Cregan is likely asking a lot of questions and requesting statements from the board on how/why they ended up here with an asset that had and have buyers lined up.
0 · Reply
1stPlace
1stPlace May. 13 at 7:16 PM
$ITRM Does anyone know if the bidders know who each are? Can they see who is bidding and what the amounts are or it is unknown?
3 · Reply
thasif1991
thasif1991 May. 13 at 6:49 PM
$ITRM waiting for new predictions!!!
0 · Reply
Digger22
Digger22 May. 13 at 6:14 PM
$ITRM
0 · Reply
jemer
jemer May. 13 at 5:44 PM
$ITRM Why isn't SOA, filed a few weeks ago, available to the public?
1 · Reply
StonkZombie
StonkZombie May. 13 at 4:09 PM
$ITRM Hard to believe this hasn't sold for $1267.50 per share yet. Any day now. Incredible drug. Hidden gem. Fishman only bailed as CEO and refused to buy shares because he's playing 4D chess with Pfizer.
1 · Reply
Amb8675309
Amb8675309 May. 13 at 3:39 PM
$ITRM OK no mention at all of any additional oral antibiotics so we’re really in the dark here. It could be that a competing BP upped their offer and no one‘s going to announce/hint at anything until they know for sure they’re buying ORLY. so really it’s a waiting game for us. saying it’s a done deal and that shares were locked over a month ago: think we have to realize everybody’s hopeful but people can get things wrong.
1 · Reply
Ricobeard
Ricobeard May. 13 at 10:33 AM
$ITRM find a new stock lol
1 · Reply
Amb8675309
Amb8675309 May. 13 at 6:56 AM
$ITRM waiting for Shionogi May 13/26 analyst call to be posted in English. They’re projecting 40% FY2027 revenue growth forecast, and new U.S. product launches(plural), beyond RADICAVA… tied perhaps to all the new PCP sales rep hires????
3 · Reply
Mateothegreat
Mateothegreat May. 12 at 4:41 PM
$ITRM been noticing a tendency of people predicting timelines lately and I just want to point out that it’s only a smidge over a month from the wind up announcement and SOA was just announced last week. While I’m sure the buyer is eager to take over assets we’re talking about potentially hundreds of millions of doll hairs being spent. I’d imagine it’ll take some time from wind up announcement to sale. Just gotta wait and be patient. Predicting the date of announcement will only add stress….my ai buddy said expect it to be 1-3 months from now we get details on it
3 · Reply
EarlyRetirement0077
EarlyRetirement0077 May. 12 at 4:10 PM
$ITRM really getting impatient here folks -____-
1 · Reply
DollerADay
DollerADay May. 12 at 2:55 PM
$ITRM By filing 3/27 rather than waiting two days for the quarter to end, implies urgency. That urgency must be substantiated to the High Court or it will cause serious issues. Had there been little interest or even one buyer, this would have been sold by now. This length thus far, is likely positive given the structure, sequence and timing. Any sale price that is material creates significant scrutiny by Justice Cregan. It is his obligation to reconcile what prevented saving a drug with modest debt and a valuable asset with all 3 PBM insurance coverage and Medicare D just kicking in from staying afloat. You can’t find a drug like this ever in liquidation, or even bankruptcy. Patience, Teneo is the best of the best in processes like this.
2 · Reply
blackdollarr
blackdollarr May. 12 at 2:33 PM
$ITRM Companies expecting absolutely no downstream process sometimes simply cancel shares outright, that suggest we might be entitled to something. That something is 0.1 or 1 or 3 / share nobody knows.
1 · Reply
YakoCapital
YakoCapital May. 12 at 2:27 PM
$ITRM Calm down and let nature take it's course. Fish is a POS though...
1 · Reply
Adagio8989
Adagio8989 May. 12 at 2:01 PM
$ITRM so what now? Back to square 1? Just waiting liquidation process? Any updates? Any clue how much we can return? Should i believe sionogi buy Orlynvah for 12.04$/shares? It's hard to wait for conclusion without knowing nothing. Oh, i know fishhead was worst or vicious ceo ever!.
3 · Reply
Toptopy
Toptopy May. 12 at 12:50 PM
$ITRM Search about “Steven Zelenk”
6 · Reply